Rheumatoid Arthritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Experiments were performed in cultured FLS from wild-type (WT) and ASIC3-/- mice, ASIC1-/- mice, and people with rheumatoid arthritis.
|
24923411 |
2014 |
Congestive heart failure
|
0.010 |
Biomarker
|
disease |
BEFREE |
While blockade of ASIC1 through amiloride, a potassium sparing diuretic that is currently licensed for hypertension and congestive cardiac failure, showed neuroprotective and myeloprotective effects in experimental models of multiple sclerosis, this strategy remains untested in patients with multiple sclerosis.
|
23365093 |
2013 |
Multiple Sclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
While blockade of ASIC1 through amiloride, a potassium sparing diuretic that is currently licensed for hypertension and congestive cardiac failure, showed neuroprotective and myeloprotective effects in experimental models of multiple sclerosis, this strategy remains untested in patients with multiple sclerosis.
|
23365093 |
2013 |
Lesion of brain
|
0.010 |
AlteredExpression
|
group |
BEFREE |
First, we assessed ASIC1 expression in chronic brain lesions from post-mortem of patients with progressive multiple sclerosis to identify the target process for neuroprotection.
|
23365093 |
2013 |
Interstitial Cystitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We assayed mRNA expression of the TRP family of channels and ASIC1 in bladder tissue from patients with interstitial cystitis.
|
23727186 |
2013 |
Chronic interstitial cystitis
|
0.010 |
Biomarker
|
disease |
BEFREE |
We assayed mRNA expression of the TRP family of channels and ASIC1 in bladder tissue from patients with interstitial cystitis.
|
23727186 |
2013 |
Multiple Sclerosis, Primary Progressive
|
0.010 |
Biomarker
|
disease |
BEFREE |
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
|
23365093 |
2013 |
Progressive multiple sclerosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
First, we assessed ASIC1 expression in chronic brain lesions from post-mortem of patients with progressive multiple sclerosis to identify the target process for neuroprotection.
|
23365093 |
2013 |
Migraine with Aura
|
0.010 |
Biomarker
|
disease |
BEFREE |
Acid-sensing ion channel 1: a novel therapeutic target for migraine with aura.
|
23109150 |
2012 |
Adult Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration.
|
19561078 |
2009 |
Childhood Glioblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Knockdown of ASIC1 and epithelial sodium channel subunits inhibits glioblastoma whole cell current and cell migration.
|
19561078 |
2009 |
Huntington Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
|
18658163 |
2008 |
Ischemia
|
0.010 |
Biomarker
|
phenotype |
LHGDN |
Endogenous arginine-phenylalanine-amide-related peptides alter steady-state desensitization of ASIC1a.
|
17984098 |
2008 |
Cerebrovascular accident
|
0.010 |
Biomarker
|
group |
LHGDN |
Endogenous arginine-phenylalanine-amide-related peptides alter steady-state desensitization of ASIC1a.
|
17984098 |
2008 |
Adenoid Cystic Carcinoma
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Identification of acid-sensing ion channels in adenoid cystic carcinomas.
|
17324378 |
2007 |
Machado-Joseph Disease
|
0.010 |
Biomarker
|
disease |
LHGDN |
Research on screening and identification of proteins interacting with ataxin-3.
|
15952105 |
2005 |
Malignant neoplasm of stomach
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Analysis of Polymorphism and Expression Profile of ASIC1 and IL-6 Genes in Patients with Gastric Cancer
|
30583668 |
2018 |
Malignant neoplasm of stomach
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Down-regulation of ASIC1 suppressed gastric cancer via inhibiting autophagy.
|
28111260 |
2017 |
Anxiety
|
0.020 |
Biomarker
|
disease |
BEFREE |
Our findings support previously reported associations between ASIC1 and panic/anxiety, but not other genes previously associated with anxiety disorders.
|
25913301 |
2015 |
Glioblastoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Regulation of ASIC1 by Ca2+/calmodulin-dependent protein kinase II in human glioblastoma multiforme.
|
24100685 |
2013 |
Glioblastoma Multiforme
|
0.020 |
Biomarker
|
disease |
BEFREE |
However, it has not been determined whether Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates ASIC1 in glioblastoma multiforme (GBM).
|
24100685 |
2013 |
Glioblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Using quantitative real time PCR, we have shown higher expression of ASIC1, alphaENaC, and gammaENaC in D54-MG human glioblastoma multiforme cells compared with primary human astrocytes.
|
19561078 |
2009 |
Glioblastoma Multiforme
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Using quantitative real time PCR, we have shown higher expression of ASIC1, alphaENaC, and gammaENaC in D54-MG human glioblastoma multiforme cells compared with primary human astrocytes.
|
19561078 |
2009 |
Anxiety
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Although the ACCN2 gene may play a role in rodent fear conditioning, we could not detect association with genetic risk shared among human anxiety spectrum disorders.
|
18349698 |
2008 |
Hypertensive disease
|
0.030 |
Biomarker
|
group |
BEFREE |
We previously reported that ASIC1 in pulmonary artery smooth muscle cells (PASMC) contribute to pulmonary vasoreactivity and vascular remodeling during the development of chronic hypoxia (CH)-induced pulmonary hypertension.
|
31169471 |
2019 |